Discussion
Diagnosis With Brief Discussion
- Diagnosis
- PAP(pulmonary alveolar proteinosis) with secondary aspergillus Infection
- Radiologic Findings
- Fig 1. Chest PA shows diffuse GGO in both lungs and irregular consolidation in the RMLF and BLLFs.
Fig 2-3. CT scans reveals diffuse GGO with crazypaving pattern in both lungs.
Fig 4-5. Previous diffuse GGO with crazypaving pattern in both lungs were partially decreased and partially increased. In addition, subpleural or peribronchial consolidation with GGO in both lungs were newly developed. Subpleural consolidation in the LLL showed internal necrotic change.
- Brief Review
- The patient underwent wedge resection of the right upper and right lower lobe and pulmonary alveolar proteinosis was diagnosed in the right upper lobe specimen. In the right lower lobe specimen, fungal hyphae were found along with pulmonary alveolar proteinosis and confirmed as Aspergillosis. After antifungal treatment, consolidations with GGO were resolved and extent of GGOs with crazypaving pattern were decreased.
Pulmonary alveolar proteinosis (PAP) is a rare disease. The prevalence ranged from 4 to 40 cases in every 1 million population with an incidence of 0.2-0.42 cases for every 1 million population every year. In general, PAP is a condition with deposition of surfactant, a lipoprotein, in the alveolar space and can be accompanied by alveolar macrophage dysfunction. In patients with PAP, the gas exchange process is disrupted and causes various respiratory issues with the increased risk
of secondary infection.
PAP can be classified into three types based on its pathophysiology as primary, secondary, and congenital. In primary PAP, there is a disturbance of GM-CSF signaling, causing a reduction in surfactant clearance. GM-CSF is a cytokine with an important role in surfactant homeostasis and is secreted by many cells, including the type II alveolar epithelial, and can be classified further as autoimmune (increase in anti-GM-CSF antibody) or hereditary (CSF2RA or CSF2RB gene mutation). More than 90% of PAP cases are autoimmune. In secondary PAP, there is a decrease in the number and/or function of the alveolar macrophages due to certain health conditions or substance exposures, such as myelodysplastic syndrome, myeloid leukemia (acute and chronic), cigarette smoke exposure, and inhalation of silica or other mineral and metal particles. PAP can also be caused by the abnormality of surfactant production as in congenital PAP.
Secondary infection is the most common complication occurring in autoimmune PAP and is life-threatening. Around 5-13% of PAP patients have a secondary infection. Infections can be caused by general pathogens (Streptococcus, Haemophilus, and Enterobacter) and opportunistic pathogens (Mycobacterium, Nocardia, Actinomyces, Aspergillus, and Cryptococcus). From the many pathogens, Aspergillus, Mycobacterium, and Nocardia are the most common infection source in autoimmune PAP. From Japanese national PAP registry, most of the infections in autoimmune PAP are caused by Aspergillus spp.
- References
- 1. Jouneau S, Menard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology 2020;25(8):816-826.
2. Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, et al. Pulmonary alveolar proteinosis. Nat Rev 2019;5(1):16.
3. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003;349(26):2527-2539
4. Borie R, Danel C, Debray MP, Taille C, Dombret MC, Aubier M, et al. Pulmonary alveolar proteinosis. Eur Respir Rev 2011;20(120):98-107
5. Fanny Fachrucha, et al.: PAP with Secondary Aspergillus Infection Journal of Health Sciences 2021;11(3):191-195
- Keywords